Bridging molecular research and clinical applications to advance cancer diagnostics and precision oncology. Expertise in ctDNA, biomarker discovery, and genomic profiling.
Years of Experience
Completed Projects
Awards Winning
Positive Reviews
University of Dhaka — CGPA 3.97 / 4.00 (1st)
Expression Status of HER2 and Its Oncogenic Alterations in Bangladeshi Breast Cancer Patients: A demographic, in-silico and ctDNA-based study.
Supervisor: Dr. Mustak Ibn Ayub, University of Dhaka
01.
A demographic, in silico, and ctDNA-based molecular investigation to identify HER2-driven oncogenic alterations.
2022
02.
Comprehensive molecular and structural overview of SARS-CoV-2 proteins with emphasis on therapeutic target identification.
2023
03.
Early-stage epidemiological and management analysis across SAARC countries.
2020
04.
Focused exploration on breast cancer–related genomic alterations including HER2 & PIK3CA mutations in Bangladeshi patients.
2020 – Present
05.
Development of cfDNA fragmentation–based signatures for non-invasive early cancer detection.
2023–Present
06.
Computational modeling to reveal structural and regulatory roles of Golgi proteins in cancer progression.
2023
07.
Mutation profiling & clinical correlation of hereditary lymphedema-distichiasis cases in Bangladesh.
2021–2022
08.
Analysis of tumor features, receptor status, and treatment pathways in Bangladeshi cervical cancer patients.
2022–2024
09.
Identification of MDR genes in bacteria from smoker oral cancer patients compared to smoker healthy individuals.
2021–2022
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar leo.
Biotechnology Program, Department of Mathematics & Natural Sciences — BRAC University
Sept 22, 2022 – Present
Dept. of Genetic Engineering & Biotechnology — University of Dhaka
Apr 21, 2022 — Sept 20, 2022
Screening chemoresistance-associated mutations to support precision therapy in breast cancer.
Developing cfDNA fragmentation profiles for early, non-invasive cancer diagnostics.
2023–Present
Computational interpretation of Golgi-associated proteins to understand their oncogenic impact.
2023
Studying receptor profiles and tumor behavior to guide improved treatment decisions.
2023
Identifying predictive biomarkers and risk factors associated with tumor progression.
2023
/ 2023
/ 2021
/ 2020
/ 2019
/ 2019
/ 2015
/ 2013
Federation of Asian Biotech Associations (FABA)
Certificate course on interactive and student-centered teaching strategies for effective post-COVID pedagogy.
Foundation for Learning, Teaching and Research (fLTR)
Hands-on training on modern drug discovery processes, development pipelines, and translational applications.
National Institute of Biotechnology
Applied training on bioinformatics tools and techniques for genetic and molecular biology research.
FABA Bangladesh Chapter
Training on laboratory safety, biohazard management, and biosecurity protocols in biotechnology research.
Ministry of Primary and Mass Education
Project-based workshop focused on educational technology and innovative learning solutions.
ESCO
Seminar on correct and safe operation of laboratory ventilation systems to ensure biosafety.
Have a question or idea? I’d love to hear from you—drop me a message anytime.
Let’s connect professionally and stay updated on my latest work and insights.
Lecturer and Translational Oncologist with a strong academic foundation from the University of Dhaka. My work focuses on translating genomic discoveries into diagnostic tools and clinical strategies for cancer care.
© Mahmuda Kabir — Translational Oncologist & Lecturer | BRAC University | Made with 🧡 by TECHABYTE SOLUTIONS
